| # | Title | Journal | Year | Citations |
|---|
| 1 | Peritoneal Equilibration Test | Peritoneal Dialysis International | 1987 | 867 |
| 2 | Peritoneal Dialysis-Related Infections Recommendations: 2010 Update | Peritoneal Dialysis International | 2010 | 770 |
| 3 | ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment | Peritoneal Dialysis International | 2016 | 745 |
| 4 | Sotalol-Lnduced Torsade De Pointes in a Capd Patient -Successful Treatment with Intermittent Peritoneal Dialysis | Peritoneal Dialysis International | 1997 | 424 |
| 5 | Pathogenesis of Peritoneal Fibrosing Syndromes (Sclerosing Peritonitis) in Peritoneal Dialysis | Peritoneal Dialysis International | 1992 | 341 |
| 6 | Encapsulating Peritoneal Sclerosis: Definition, Etiology, Diagnosis, and Treatment | Peritoneal Dialysis International | 2000 | 328 |
| 7 | Peritoneal dialysis-related infections recommendations: 2005 update | Peritoneal Dialysis International | 2005 | 304 |
| 8 | Vascular and Interstitial Changes in the Peritoneum of Capd Patients with Peritoneal Sclerosis | Peritoneal Dialysis International | 1999 | 281 |
| 9 | The Peak Concentration Hypothesis: A Urea Kinetic Approach to Comparing the Adequacy of Continuous Ambulatory Peritoneal Dialysis (CAPD) and Hemodialysis | Peritoneal Dialysis International | 1989 | 276 |
| 10 | ISPD Position Statement on Reducing the Risks of Peritoneal Dialysis–Related Infections | Peritoneal Dialysis International | 2011 | 273 |
| 11 | Evaluation and Management of Ultrafiltration Problems in Peritoneal Dialysis | Peritoneal Dialysis International | 2000 | 272 |
| 12 | Peritoneal Catheters and Exit-Site Practices toward Optimum Peritoneal Access: 1998 Update | Peritoneal Dialysis International | 1998 | 266 |
| 13 | Peritonitis-Related Mortality in Patients Undergoing Chronic Peritoneal Dialysis | Peritoneal Dialysis International | 2005 | 250 |
| 14 | ISPD Catheter-Related Infection Recommendations: 2017 Update | Peritoneal Dialysis International | 2017 | 239 |
| 15 | Pathophysiology of Peritoneal Membrane Failure | Peritoneal Dialysis International | 2000 | 228 |
| 16 | Nutritional Status of Korean Peritoneal Dialysis Patients | Peritoneal Dialysis International | 1999 | 224 |
| 17 | Peritonitis Remains the Major Clinical Complication of Peritoneal Dialysis: The London, Uk, Peritonitis Audit 2002–2003 | Peritoneal Dialysis International | 2009 | 222 |
| 18 | Clinical Practice Guidelines for Peritoneal Access | Peritoneal Dialysis International | 2010 | 222 |
| 19 | Consensus Guidelines for the Prevention and Treatment of Catheter-Related Infections and Peritonitis in Pediatric Patients Receiving Peritoneal Dialysis: 2012 Update | Peritoneal Dialysis International | 2012 | 216 |
| 20 | ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment | Peritoneal Dialysis International | 2022 | 209 |
| 21 | Creating and Maintaining Optimal Peritoneal Dialysis Access in the Adult Patient: 2019 Update | Peritoneal Dialysis International | 2019 | 208 |
| 22 | Determination of Individual Ultrafiltration Time (Apex) and Purification Phosphate Time by Peritoneal Equilibration Test: Application to Individual Peritoneal Dialysis Modality Prescription in Children | Peritoneal Dialysis International | 1996 | 207 |
| 23 | A Multicenter, Selection-Adjusted Comparison of Patient and Technique Survivals on CAPD and Hemodialysis | Peritoneal Dialysis International | 1991 | 201 |
| 24 | Reviews and Original Articles | Peritoneal Dialysis International | 1996 | 192 |
| 25 | Peritoneal Dialysis for Acute Kidney Injury | Peritoneal Dialysis International | 2014 | 191 |
| 26 | A Three-Pore Model of Peritoneal Transport | Peritoneal Dialysis International | 1993 | 189 |
| 27 | Heat Sterilization of Fluids for Peritoneal Dialysis Gives Rise to Aldehydes | Peritoneal Dialysis International | 1993 | 187 |
| 28 | Microbiology and Outcomes of Peritonitis in Australian Peritoneal Dialysis Patients | Peritoneal Dialysis International | 2011 | 183 |
| 29 | Peritonitis in Continuous Ambulatory Peritoneal Dialysis {CAPD): A Multi-Centre Randomized Clinical Trial Comparing the Y Connector Disinfectant System to Standard Systems | Peritoneal Dialysis International | 1989 | 181 |
| 30 | Risk Factors for Abdominal Wall Complications in Peritoneal Dialysis Patients | Peritoneal Dialysis International | 2003 | 176 |
| 31 | Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis | Peritoneal Dialysis International | 1999 | 174 |
| 32 | Treatment Recommendations 1993 Update | Peritoneal Dialysis International | 1993 | 173 |
| 33 | Peritoneal Catheters and Exit-Site Practices toward Optimum Peritoneal Access: A Review of Current Developments | Peritoneal Dialysis International | 2005 | 169 |
| 34 | Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis | Peritoneal Dialysis International | 1992 | 164 |
| 35 | Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update | Peritoneal Dialysis International | 2000 | 162 |
| 36 | Calculation of the Protein Equivalent of Total Nitrogen Appearance from Urea Appearance. Which Formulas Should be Used? | Peritoneal Dialysis International | 1998 | 161 |
| 37 | The Efficacy of Silver-Ion Implanted Catheters in Reducing Peritoneal Dialysis-Related Infections | Peritoneal Dialysis International | 2003 | 160 |
| 38 | International Society for Peritoneal Dialysis practice recommendations: Prescribing high-quality goal-directed peritoneal dialysis | Peritoneal Dialysis International | 2020 | 159 |
| 39 | Fluid Status, Blood Pressure, and Cardiovascular Abnormalities in Patients on Peritoneal Dialysis | Peritoneal Dialysis International | 2002 | 158 |
| 40 | Basic Mechanisms and Clinical Implications of Peritoneal Fibrosis | Peritoneal Dialysis International | 2003 | 158 |
| 41 | Posterior Reversible Encephalopathy Syndrome: A Truly Treatable Neurologic Illness | Peritoneal Dialysis International | 2012 | 157 |
| 42 | Characteris Tics and Causes of Immune Dysfunction Related to Uremia and Dialysis | Peritoneal Dialysis International | 2008 | 154 |
| 43 | Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update | Peritoneal Dialysis International | 1996 | 154 |
| 44 | Recommended Clinical Practices for Maximizing Peritoneal Dialysis Clearances | Peritoneal Dialysis International | 1996 | 153 |
| 45 | Emergence of Mupirocin-Resistant Staphylococcus Aureus in Chronic Peritoneal Dialysis Patients using Mupirocin Prophylaxis to Prevent Exit-Site Infection | Peritoneal Dialysis International | 2001 | 153 |
| 46 | Peritoneal Sclerosis in Chronic Peritoneal Dialysis Patients: Analysis of Clinical Presentation, Risk Factors, and Peritoneal Transport Kinetics | Peritoneal Dialysis International | 1997 | 152 |
| 47 | A Prospective, Randomized Multicenter Study Comparing APD and CAPD Treatment | Peritoneal Dialysis International | 1999 | 152 |
| 48 | Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003 | Peritoneal Dialysis International | 2009 | 151 |
| 49 | Time-Dependent Reasons for Peritoneal Dialysis Technique Failure and Mortality | Peritoneal Dialysis International | 2010 | 150 |
| 50 | Serum C-Reactive Protein: A Predictor of Mortality in Continuous Ambulatory Peritoneal Dialysis Patients | Peritoneal Dialysis International | 1998 | 149 |
